IMMUNOLOGICAL PARAMETERS IN BREAST CANCER PATIENTS UNDER BETALEUKIN ADJUVANT TREATMENT

Abstract. We have examined the effect of betaleukin on the immune parameters in breast cancer (BC) patients treated with cytostatic drug and surgery. Intravenous application of betaleukin for 5 days just before adjuvant chemotherapy have been shown to prevent both the decrease of blood immune cell c...

Full description

Bibliographic Details
Main Authors: M. Staheeva, E. Slonymskaya, N. Babyshkina, N. Cherdyntseva, A. Simbirtsev, A. Kladiev
Format: Article
Language:Russian
Published: St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:Медицинская иммунология
Subjects:
Online Access:https://www.mimmun.ru/mimmun/article/view/427